433 related articles for article (PubMed ID: 26504450)
1. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
Manghelli J; Brown L; Tadros HB; Munfakh NA
Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
[TBL] [Abstract][Full Text] [Related]
2. To the Editor.
Manghelli J; Brown L; Munfakh NA; Tadros HB
Tex Heart Inst J; 2016 Feb; 43(1):103. PubMed ID: 27504507
[No Abstract] [Full Text] [Related]
3. Methylene Blue Is a Guanylate Cyclase Inhibitor That Does Not Interfere with Nitric Oxide Synthesis.
Evora PR
Tex Heart Inst J; 2016 Feb; 43(1):103. PubMed ID: 27047301
[No Abstract] [Full Text] [Related]
4. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
Lenglet S; Mach F; Montecucco F
Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1519-25. PubMed ID: 22103871
[TBL] [Abstract][Full Text] [Related]
5. Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.
Peyko V; Finamore M
Am J Case Rep; 2021 Jun; 22():e930890. PubMed ID: 34143764
[TBL] [Abstract][Full Text] [Related]
6. Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation.
Carley M; Schaff J; Lai T; Poppers J
A A Case Rep; 2015 Oct; 5(8):127-30. PubMed ID: 26466303
[TBL] [Abstract][Full Text] [Related]
7. Methylene Blue for Vasoplegic Syndrome.
Booth AT; Melmer PD; Tribble B; Mehaffey JH; Tribble C
Heart Surg Forum; 2017 Oct; 20(5):E234-E238. PubMed ID: 29087290
[TBL] [Abstract][Full Text] [Related]
8. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery.
Levin RL; Degrange MA; Bruno GF; Del Mazo CD; Taborda DJ; Griotti JJ; Boullon FJ
Ann Thorac Surg; 2004 Feb; 77(2):496-9. PubMed ID: 14759425
[TBL] [Abstract][Full Text] [Related]
9. [Vasoplegic syndrome after cardiac surgery with cardiopulmonary bypass].
Lehot JJ
Ann Fr Anesth Reanim; 2012 May; 31 Suppl 1():S18-21. PubMed ID: 22721515
[TBL] [Abstract][Full Text] [Related]
10. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery.
Ozal E; Kuralay E; Yildirim V; Kilic S; Bolcal C; Kücükarslan N; Günay C; Demirkilic U; Tatar H
Ann Thorac Surg; 2005 May; 79(5):1615-9. PubMed ID: 15854942
[TBL] [Abstract][Full Text] [Related]
11. Methylene blue to treat vasoplegia due to a severe protamine reaction: a case report.
Lutjen DL; Arndt KL
AANA J; 2012 Jun; 80(3):170-3. PubMed ID: 22848976
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative vasoplegia: methylene blue to the rescue!
McCartney SL; Duce L; Ghadimi K
Curr Opin Anaesthesiol; 2018 Feb; 31(1):43-49. PubMed ID: 29176374
[TBL] [Abstract][Full Text] [Related]
13. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
Shaefi S; Mittel A; Klick J; Evans A; Ivascu NS; Gutsche J; Augoustides JGT
J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):1013-1022. PubMed ID: 29223724
[TBL] [Abstract][Full Text] [Related]
14. [Methylene blue therapy for vasoplegia after cardiac surgery].
Skuza K; Chmielniak S; Dziuk W; Kucewicz E; Pawlak S; Knapik P
Anestezjol Intens Ter; 2009; 41(3):159-62. PubMed ID: 19999604
[TBL] [Abstract][Full Text] [Related]
15. Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival.
Mehaffey JH; Johnston LE; Hawkins RB; Charles EJ; Yarboro L; Kern JA; Ailawadi G; Kron IL; Ghanta RK
Ann Thorac Surg; 2017 Jul; 104(1):36-41. PubMed ID: 28551045
[TBL] [Abstract][Full Text] [Related]
16. Vasoplegic syndrome--the role of methylene blue.
Shanmugam G
Eur J Cardiothorac Surg; 2005 Nov; 28(5):705-10. PubMed ID: 16143539
[TBL] [Abstract][Full Text] [Related]
17. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.
Datt V; Wadhhwa R; Sharma V; Virmani S; Minhas HS; Malik S
J Card Surg; 2021 Oct; 36(10):3749-3760. PubMed ID: 34251716
[TBL] [Abstract][Full Text] [Related]
18. Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery: A Literature Review.
Nash CM
AACN Adv Crit Care; 2021 Jun; 32(2):137-145. PubMed ID: 34161970
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy with methylene blue in the treatment of postoperative vasoplegic syndrome caused by carcinoid crisis after tricuspid valve replacement.
Raikhelkar JK; Weiss AJ; Maysick L; Scurlock C
J Cardiothorac Vasc Anesth; 2012 Oct; 26(5):878-9. PubMed ID: 21641821
[No Abstract] [Full Text] [Related]
20. Methylene blue for vasoplegic syndrome in cardiopulmonary bypass surgery: A systematic review and meta-analysis.
Perdhana F; Kloping NA; Witarto AP; Nugraha D; Yogiswara N; Luke K; Kloping YP; Rehatta NM
Asian Cardiovasc Thorac Ann; 2021 Oct; 29(8):717-728. PubMed ID: 33653154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
